Erythromycin

BreastfeedingGeriatric
  • TRADE NAMES: E-Mycin; EES; Eramycin; Ery-Ped; Ery-Tab; Eryc (Warner Chilcott); Erypar; Erythrocin; Eryzole; Ilosone; Ilotycin; PCE (AbbVie); Pediazole; Robimycin; Wintrocin; Wyamicin S
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Antibiotic, macrolide, CYP3A4 inhibitor
  • HALF-LIFE: 1.4–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Afatinib, Alfentanil, Aminophylline, Amisulpride, Amoxicillin, Ampicillin, Anticonvulsants, Arsenic, Astemizole, Atorvastatin, Avanafil, Benzodiazepines, Bosentan, Bromocriptine, Buprenorphine, Bupropion, Carbamazepine, Cilostazol, Ciprofloxacin, Cisapride, Clindamycin, Clindamycin/Tretinoin, Clopidogrel, Clozapine, Colchicine, Cyclosporine, CYP3A inhibitors, Darifenacin, Dasatinib, Digoxin, Dihydroergotamine, Diltiazem, Disopyramide, Docetaxel, Doxercalciferol, Dronedarone, Enoxacin, Eplerenone, Ergotamine, Estradiol, Eszopiclone, Everolimus, Flibanserin, Fluconazole, Fluoxetine, Fluvastatin, Gatifloxacin, HMG-CoA reductase inhibitors, Imatinib, Indacaterol, Itraconazole, Ketoconazole, Levodopa, Lomefloxacin, Lorazepam, Lovastatin, Methadone, Methylergonovine, Methylprednisolone, Methysergide, Midazolam, Mifepristone, Mizolastine, Moxifloxacin, Naldemedine, Naloxegol, Neratinib, Nintedanib, Nitrazepam, Norfloxacin, Ofloxacin, Olaparib, Oxtriphylline, Paroxetine Hydrochloride, Pentamidine, Pimecrolimus, Pimozide, Pitavastatin, Pravastatin, Quetiapine, Quinolones, Ranolazine, Repaglinide, Rilpivirine, Rivaroxaban, Roflumilast, Rosuvastatin, Rupatadine, Sertraline, Sildenafil, Silodosin, Simeprevir, Simvastatin, Sparfloxacin, Sulpiride, Tacrolimus, Tadalafil, Tamsulosin, Terfenadine, Tezacaftor/Ivacaftor, Tramadol, Triamcinolone, Triazolam, Troleandomycin, Vardenafil, Venetoclax, Verapamil, Vilazodone, Vinblastine, Warfarin, Zafirlukast, Zaleplon, Zolpidem, Zuclopenthixol

PREGNANCY CATEGORY: B

Our database has 65 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
HEMATOLOGIC
LOCAL
NEUROMUSCULAR/SKELETAL
OCULAR
OTIC
RENAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric